Overview
Nuclivision operates in the nuclear medicine sector, positioning itself around future-proof technologies and approaches in this medical field.
Key people
In the news
- What a fantastic few days at EANM 2026! 🇦🇹 And just like that, another incredible EANM Congress is coming to an end! From insightful conversations, talks, networking and reconnecting with familiar faces, Vienna has been an amazing experience for the Nuclivision team. We've loved welcoming nuclear medicine professionals from around the world to our booth, sharing the latest developments in NUCLARITY, and exploring how AI can help make PET imaging more efficient and accessible. A huge thank you to everyone who stopped by, joined
- A proud moment for Nuclivision: NUCLARITY in the spotlight at EANM 2026! 🇦🇹 It was fantastic to see our clinical validation paper featured during a presentation at #EANM2026! 💙 Seeing our research recognised and shared with the wider nuclear medicine community is a reminder of why rigorous clinical validation matters. This study evaluated NUCLARITY, our deep learning-based PET denoising solution, across multiple tracers, demonstrating strong generalisability and preserved diagnostic accuracy even at 50% count levels. From
- A fantastic second day at EANM for Nuclivision! It's been an exciting start yesterday, with a constant flow of visitors and inspiring conversations at our booth! 🙌 From existing customers and new prospects to people who discovered us through colleagues and potential collaboration partners, it's been great to see the growing interest in what we're doing at Nuclivision. We've connected with professionals from India, Latvia, Bosnia and Herzegovina, Cyprus, Greece, Mexico, Costa Rica, and many more countries. Beyond the
- NUCLIVISION TAKES CENTRE STAGE AT EANM 2026.Today we’re highlighting two scientific stories from Nuclivision. 🧠 Amyloid PET - OP-375 This morning Gloria Garelli from University of Turin and Université de Genève took the stage to present the results from the multicentre study across Geneva, Turin and Genoa where AI-powered denoising was used in early phase amyloid PET and evaluated whether a 3-min scan is more sensitive for hypoperfusion and more tightly reflects neurodegeneration linked to Tau-load. In case you've missed it: reach
- Our booth has officially come to life in Vienna and we're ready to welcome the EANM community! 🚀 We're looking forward to what EANM is really about: connecting with the nuclear medicine community, exchanging ideas and exploring how smarter PET imaging can make a difference in clinical practice. Stop by to see NUCLARITY in action with live demonstrations using real clinical data, meet the team and enjoy a good conversation over coffee. ☕ 📍 Hall X5 | Booth 519 📅 18–21 October | Vienna 👉 Book a meeting with our team:
- EANM 2026 STARTS TODAY.We’re officially in Vienna. If you’re attending EANM, come and find the Nuclivision team at: 📍 Booth 519 | Hall X5 We’ll be talking about the practical questions facing PET departments: How do we scan more patients? How do we reduce pressure on scanner capacity? How do we use AI without disrupting clinical workflows? And how do we make sure innovation is backed by clinical evidence? Come and see Nuclarity live and explore the research behind it. https://lnkd.in/ennp7zvp 👋 See you at #EANM. #EANM2026
- EANM 2026 STARTS TODAY.We’re officially in Vienna. If you’re attending EANM, come and find the Nuclivision team at: 📍 Booth 519 | Hall X5 We’ll be talking about the practical questions facing PET departments: How do we scan more patients? How do we reduce pressure on scanner capacity? How do we use AI without disrupting clinical workflows? And how do we make sure innovation is backed by clinical evidence? Come and see Nuclarity live and explore the research behind it. https://lnkd.in/ennp7zvp 👋 See you at EANM. #EANM2026
- TOMORROW, WE’RE AT EANM 2026. HERE’S WHAT WE’RE BRINGING!The Nuclivision team is getting ready for five days of nuclear medicine, research and clinical conversations in Vienna. At Booth 519, Hall X5, come and talk to us about: 🔹 Faster PET scans 🔹 Increasing patient throughput 🔹 Lower injected activity 🔹 AI-powered image enhancement 🔹 Clinical evidence 🔹 Real-world implementation We’ll also be sharing scientific work across paediatric PET and Alzheimer’s imaging! 👋 Come meet the team. 💻 See Nuclarity in action. 💬
Alumni
Maarten LarmuseauSenior Data Scientist
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.